We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Alopecia reversible secundaria a metilfenidato OROS.
- Authors
Núnez-Garces, Marta; Sánchez-Gayango, Agustín; Romero-Pérez, Cristina
- Abstract
Introduction: Attention deficit hyperactivity disorder has a prevalence of 1-4% of the Spanish school population. Its treatment consists of giving amphetamine derivatives and, recently, non-stimulant drugs, without finding any differences in efficacy in the studies performed. Clinical case: A 7-year-old girl was referred from neurology due to learning delay and behaviour disorders. Diagnosed as likely ADHD, treatment was started with immediate release methylphenidate, and later with an osmotic release oral system (OROS) methylphenidate. When alopecia areata appeared, this treatment was withdrawn. After the re-introduction of modified release methylphenidate 30:70, symptom control was achieved without the appearance of alopecia.
- Subjects
ATTENTION-deficit hyperactivity disorder; BEHAVIOR disorders; METHYLPHENIDATE; SYMPTOMS; DRUG side effects; ALOPECIA areata
- Publication
Revista Colombiana de Psiquiatria, 2020, Vol 49, Issue 3, p208
- ISSN
0034-7450
- Publication type
Article
- DOI
10.1016/j.rcp.2018.09.003